| |
|
|
|
|
|
|
|||
|
Blood, 15 May 2004, Vol. 103, No. 10, pp. 3744-3750. Prepublished online as a Blood First Edition Paper on February 5, 2004; DOI 10.1182/blood-2003-09-3126.
HEMATOPOIESIS Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3From the Turku Centre for Biotechnology, University of Turku/Åbo Akademi University; the Turku Graduate School of Biomedical Sciences; the Haartman Institute, the Department of Virology; the Biomedicum Helsinki, Programme for Developmental and Reproductive Biology; the Institute of Medical Technology, University of Tampere; and the Department of Clinical Microbiology, Tampere University Hospital, Finland.
Signal transducer and activator of transcription 5 (STAT5) plays a critical role in cytokine-induced survival of hematopoietic cells. One of the STAT5 target genes is pim-1, which encodes an oncogenic serine/threonine kinase. Here we demonstrate that Pim-1 inhibits STAT5-dependent transcription in cells responsive to interleukin-3, prolactin, or erythropoietin. Ectopic expression of Pim-1 in cytokine-dependent FDCP1 myeloid cells results in reduced tyrosine phosphorylation and DNA binding of STAT5, indicating that Pim-1 interferes already with the initial steps of STAT5 activation. However, the Pim-1 kinase does not directly phosphorylate or bind to STAT5. By contrast, Pim-1 interacts with suppressor of cytokine signaling 1 (SOCS1) and SOCS3 and potentiates their inhibitory effects on STAT5, most likely via phosphorylation-mediated stabilization of the SOCS proteins. Thus, both Pim and SOCS family proteins may be components of a negative feedback mechanism that allows STAT5 to attenuate its own activity.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2004 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||